Skip to content

Reading your DXA results over time: tracking fat vs. lean mass on a GLP-1

Your second DXA report is only useful if you can tell real change from measurement noise. Here's how to read the key numbers over time — fat mass, lean mass, body fat %, visceral fat, bone density — what a good GLP-1 trajectory looks like, why small changes may be noise, and how to shift the fat-to-lean loss ratio.

Updated Jul 18, 2026Evidence-backed

You got the baseline scan, you did the work, and now the second report is in your hands — two columns of numbers that are supposed to tell you whether the last few months went the way you hoped. The trick is knowing which of those numbers actually moved, and which just wobbled.

If you haven't had your first scan yet, start with our companion guide on getting a DXA scan and what it measures. This one picks up afterward: how to read a report against your last one and tell real change from measurement noise.

The numbers that matter, and what "better" looks like

A DXA report hands you more figures than you need. The ones worth watching over time are:

  • Total mass — your weight, the same number the scale gives you, and the least informative one here.
  • Fat mass — total fat in kilograms or pounds, plus a breakdown by region (arms, legs, trunk). This is the number you most want to see fall.
  • Lean mass (sometimes labeled lean soft tissue or fat-free mass) — muscle and everything else that isn't fat or bone. The number you most want to protect.
  • Body fat percentage — fat mass divided by total mass. Useful, but it can move just because one of its two inputs moved, so read it alongside the raw kilograms, not instead of them.
  • Visceral fat (VAT) — the metabolically active fat around your organs. Often the fastest-improving number early in GLP-1 treatment, but also the least precise one on the report (more on that below).
  • Bone mineral density — carried over from DXA's original job as an osteoporosis screen. It changes slowly, so don't expect meaningful movement between scans a few months apart.

On a GLP-1, a good trajectory is straightforward to describe and harder to achieve: fat mass down, lean mass holding as steady as you can keep it. A drop in total weight that is almost entirely fat, with lean mass barely changed, is the outcome you're training and eating for. Falling lean mass alongside the fat is expected to some degree — but it's the signal to double down on protein and resistance work, not to celebrate the smaller number on the scale.

The precision trap: small changes may be noise

Here is the caveat that saves people from over-reacting to a single report. DXA is precise, but it isn't perfect. According to PubMed, a 2026 study measuring people twice in a row put DXA's precision error (coefficient of variation) at roughly 1% for whole-body fat mass and under 1% for fat-free mass — tight, but not zero (DOI (external link)). In practical terms, an earlier study found the repeat-scan error for whole-body fat mass was around 0.5 kg and for lean mass around 0.6–0.7 kg, and it used the International Society for Clinical Densitometry method to calculate a "least significant change" — the smallest difference between two scans that is real rather than machine variability (DOI (external link)).

The upshot: if your lean mass reads half a kilogram lower than last time, that may be noise, not muscle. A change only becomes trustworthy once it clears that least-significant-change threshold — which is why the trend across three or four scans tells you far more than any single scan-to-scan difference. Regional numbers are noisier still, and visceral fat is the noisiest of all: one precision study measured a VAT error near 16%, versus about 1.4% for whole-body fat (DOI (external link)). Treat a big VAT swing as a rough direction, not a decimal-point fact.

Scan the same way every time

Because you're chasing changes that can be smaller than the machine's own error, consistency is everything. Two rules do most of the work:

  • Same machine, ideally the same clinic. Different DXA models don't read identically — one study found systematic differences between two densitometers large enough to require conversion equations before their numbers could be compared (DOI (external link)). A "loss" that's really just a change of scanner is a waste of a checkpoint.
  • Same hydration and fasting state. Lean-tissue readings partly reflect body water, so a scan after a big meal, a hard workout, or heavy fluids will differ from a fasted, rested one. Researchers have shown that standardizing food, fluid, and activity in the 24 hours before a scan can shrink the measurement error further (DOI (external link)). Book your scans at a similar time of day, fasted, before training, and hold that routine each time.

How much lean loss is normal — and how to shift the ratio

Some lean-mass loss is expected on a GLP-1. According to PubMed, a 2024 review in Diabetes Care reports that lean tissue can make up roughly 25–40% of total weight lost on incretin therapy — a larger share than with slower, diet-only weight loss — amounting to something like 6 kg of lean mass in trials (DOI (external link)). So if your report shows a chunk of the loss coming from lean tissue, you're in the normal range, not failing.

What you can change is how big that share is. The same review found that supervised resistance training lasting more than 10 weeks produced meaningful gains in lean mass and strength even while people lost weight — and it works best paired with adequate protein. Our guides on why strength training matters and protein, fat, and carbohydrates cover the how; your serial DXA reports are how you confirm it's actually working. A trajectory that starts at the high end of that lean-loss range and flattens out as you add training and protein is exactly the story these scans exist to tell.

This is general education and peer information, not medical advice — interpreting your specific results belongs with your prescriber or a clinician who can see the full report. Research findings here are drawn from PubMed; see the linked studies for details.

dxabody-compositionlean-masstracking-progressvisceral-fat

Was this helpful?

Common questions

Questions people often ask about this topic.

  • Which numbers on my DXA report should I actually track over time?

    The ones worth watching are fat mass (the number you most want to see fall), lean mass (the number you most want to protect), body fat percentage read alongside the raw kilograms, and visceral fat as a rough direction. Total mass is just your scale weight and is the least informative, and bone density changes too slowly to move meaningfully between scans a few months apart.

  • My lean mass dropped half a kilogram between scans — did I lose muscle?

    Not necessarily. Repeat-scan studies put DXA's error at around 0.5 kg for whole-body fat mass and 0.6–0.7 kg for lean mass, so a half-kilogram difference may be measurement noise rather than real change. A change only becomes trustworthy once it clears the "least significant change" threshold, which is why the trend across three or four scans tells you far more than any single scan-to-scan difference.

  • How much lean mass loss is normal on a GLP-1?

    Some lean loss is expected. A 2024 review reports that lean tissue can make up roughly 25–40% of total weight lost on incretin therapy — a larger share than with slower, diet-only weight loss. If part of your loss is coming from lean tissue, you're in the normal range, not failing; the share is what you can work to shrink with resistance training and adequate protein.

  • Do I need to use the same DXA machine for every scan?

    Ideally yes — same machine, same clinic. Different DXA models don't read identically; one study found systematic differences between two densitometers large enough to require conversion equations before their numbers could be compared. Also scan in the same hydration and fasting state each time, since lean-tissue readings partly reflect body water.

  • Is the visceral fat number on my DXA report reliable?

    It's the noisiest number on the report. One precision study measured visceral fat error near 16%, versus about 1.4% for whole-body fat, so treat a big visceral fat swing as a rough direction rather than a decimal-point fact. It's often the fastest-improving number early in GLP-1 treatment, but read it with that imprecision in mind.

Evidence: For & Against

Both sides of the topic, so you can weigh the evidence yourself.

3Supporting

1Mixed findings

Related guides

  • Loose skin after GLP-1 weight loss: what actually helps and what's hypeLoose or excess skin on the belly, arms, and thighs is a common worry after large GLP-1 weight loss. Here's what the evidence actually supports — gradual loss, muscle, nutrition, time — versus the creams and wraps that promise more than they deliver, and when surgery is the only real fix.
  • Liraglutide (Victoza and Saxenda): how the daily GLP-1 differsLiraglutide (Victoza for diabetes, Saxenda for weight) is the first-generation GLP-1 — a daily injection with a roughly 13-hour half-life and generally more modest weight loss than the weekly drugs. Here's what makes it distinct and why it's still worth considering.
  • What is suppression, satiation, and satiety on a GLP-1?GLP-1 medications change appetite through three related but distinct mechanisms — suppression, satiation, and satiety. Here's what each means and what to expect.
  • Safe sharps disposal for GLP-1 injectorsEvery GLP-1 injection ends with a needle you have to put somewhere. Here's the FDA's two-step system: a proper sharps container (or an acceptable heavy-duty household stand-in), the short list of things never to do with a used needle, how to find your community's disposal rules, and what changes when you travel.
  • Reading an insulin syringe: units, mL, and mg for compounded GLP-1 dosesU-100 insulin syringes mark volume in "units" — 100 per mL — and your vial's concentration is what converts a prescribed mg dose into a unit count. This walkthrough teaches the arithmetic with worked examples at different concentrations, explains the FDA-documented error patterns, and gives a verify-with-your-pharmacist checklist. It teaches reading the syringe; it does not prescribe doses.
  • GLP-1s with insulin or sulfonylureas: understanding hypoglycemia riskA GLP-1 on its own rarely causes low blood sugar, but pairing it with insulin or a sulfonylurea meaningfully raises the risk — here's why, how to recognize hypoglycemia, and what to settle with your prescriber before any dose changes.